New Key Statistics Module, Z-Score and F-Score
OTCPK:ASCLF Key Ratios
| Market Cap $ M | 1,267.01 |
| Enterprise Value $ M | 1,078.83 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 4.82 |
| Price/Sales | 5,318.33 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -0.05 |
| Beneish M-Score | -1.52 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -11.10 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -21.25 |
| EV-to-EBITDA | -21.25 |
| PEG | -- |
| Shares Outstanding M | 1,051.98 |
| Net Margin (%) | -17,798.16 |
| Operating Margin % | -22,057.32 |
| Pre-tax Margin (%) | -17,773.07 |
| Quick Ratio | 15.04 |
| Current Ratio | 15.05 |
| ROA % (ttm) | -17.67 |
| ROE % (ttm) | -18.95 |
| ROIC % (ttm) | -190.21 |
| Dividend Yield % | -- |
| Altman Z-Score | 40.03 |
ASCLF Number of Guru Trades
ASCLF Volume of Guru Trades
Gurus Latest Trades with OTCPK:ASCLF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:ASCLF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Ascletis Pharma Inc Insider Transactions
No Available Data
News about OTCPK:ASCLF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers